Key drivers of OSA in this study that were shared with human OSA included TP53, PTEN, CDKN2A/B, WRN and DLG2. CDKN2A/B deletion is more commonly observed in canine OSA (and other canine cancers) compared to human cancers. This evidence concerns the gene CDKN2A and obstructive sleep apnea syndrome.